You are here: Industry Insights > available

News List

ZELNORM Now Available In the US americanpharmaceuticalreview
August 19, 2019
Alfasigma USA announced that ZELNORM™ (tegaserod) is now available in the United States as a prescription pharmaceutical treatment for irritable bowel syndrome with constipation (IBS-C) in adult women less than 65 years of age.
MVASI, KANJINTI Now Available in United States americanpharmaceuticalreview
July 22, 2019
Amgen and Allergan announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the United States.
Naloxone Available in One in Three Philadelphia Pharmacies drugs
June 10, 2019
Naloxone Available in One in Three Philadelphia Pharmacies.
Categories available for all experience levels in the 2019 Marketer of the Year competition pharmatimes
June 05, 2019
There are a broad range of categories in the PharmaTimes Marketer of the Year competition, designed to cover all sectors and suitable for all experience levels.
New late stage prostate cancer technology available in UK pharmatimes
June 05, 2019
GenesisCare has launched a new radiotherapy technology in the UK to treat late stage prostate cancer patients, for whom there are limited treatment options available.
Ocrevus finally available on NHS pharmatimes
May 09, 2019
After 21,000 people signed a charity petition, the first primary progressive multiple sclerosis (MS) drug has been made available on the NHS.
Siklos Now Available In 1,000 mg Triple-Scored Tablets americanpharmaceuticalreview
November 20, 2018
Medunik USA announced Siklos (hydroxyurea), an FDA-approved orphan drug, is now available in 1,000 mg triple-scored tabl